Literature DB >> 8787851

Distribution of drugs following controlled delivery to the brain interstitium.

M Mak1, L Fung, J F Strasser, W M Saltzman.   

Abstract

Intracranial controlled release polymers have been used for drug delivery to the brain, bypassing the blood brain barrier (BBB). By understanding the rates and patterns of transport in the local tissues, it is possible to design delivery systems that provide the optimal spatial and temporal pattern of chemotherapy within the intracranial space. This paper reviews the kinetics of drug release from polymeric controlled release implants, and describes the fate of drug molecules following release into the brain interstitium. Potential improvements in drug delivery based on the understanding of the mechanisms of drug release, transport and elimination are discussed.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8787851     DOI: 10.1007/bf01060215

Source DB:  PubMed          Journal:  J Neurooncol        ISSN: 0167-594X            Impact factor:   4.130


  39 in total

1.  Quantitative examination of tissue concentration profiles associated with microdialysis.

Authors:  K H Dykstra; J K Hsiao; P F Morrison; P M Bungay; I N Mefford; M M Scully; R L Dedrick
Journal:  J Neurochem       Date:  1992-03       Impact factor: 5.372

2.  High-flow microinfusion: tissue penetration and pharmacodynamics.

Authors:  P F Morrison; D W Laske; H Bobo; E H Oldfield; R L Dedrick
Journal:  Am J Physiol       Date:  1994-01

Review 3.  Interstitial chemotherapy with sustained-release polymer systems for the treatment of malignant gliomas.

Authors:  A Olivi; H Brem
Journal:  Recent Results Cancer Res       Date:  1994

4.  Drug distribution in solid tissue of the brain following chronic local perfusion utilizing implanted osmotic minipumps.

Authors:  J T Lum; T Nguyen; L P Felpel
Journal:  J Pharmacol Methods       Date:  1984-09

5.  Intracerebral drug delivery in rats with lesion-induced memory deficits.

Authors:  M A Howard; A Gross; M S Grady; R S Langer; E Mathiowitz; H R Winn; M R Mayberg
Journal:  J Neurosurg       Date:  1989-07       Impact factor: 5.115

6.  [A device for prolonged releasing of anticancer drug--bleomycin (author's transl)].

Authors:  R Katakura; T Mori; K Mineura; J Suzuki
Journal:  No Shinkei Geka       Date:  1980-11

7.  Sustained behavioral recovery from unilateral nigrostriatal damage produced by the controlled release of dopamine from a silicone polymer pellet placed into the denervated striatum.

Authors:  J B Becker; T E Robinson; P Barton; A Sintov; R Siden; R J Levy
Journal:  Brain Res       Date:  1990-01-29       Impact factor: 3.252

8.  Biodegradable polymers for controlled delivery of chemotherapy with and without radiation therapy in the monkey brain.

Authors:  H Brem; R J Tamargo; A Olivi; M Pinn; J D Weingart; M Wharam; J I Epstein
Journal:  J Neurosurg       Date:  1994-02       Impact factor: 5.115

9.  Implantable microencapsulated dopamine (DA): a new approach for slow-release DA delivery into brain tissue.

Authors:  A McRae-Degueurce; S Hjorth; D L Dillon; D W Mason; T R Tice
Journal:  Neurosci Lett       Date:  1988-10-17       Impact factor: 3.046

10.  Interstitial taxol delivered from a biodegradable polymer implant against experimental malignant glioma.

Authors:  K A Walter; M A Cahan; A Gur; B Tyler; J Hilton; O M Colvin; P C Burger; A Domb; H Brem
Journal:  Cancer Res       Date:  1994-04-15       Impact factor: 12.701

View more
  14 in total

1.  Ultrasound-enhanced drug transport and distribution in the brain.

Authors:  Ying Liu; Sumit Paliwal; Krystof S Bankiewicz; John R Bringas; Gill Heart; Samir Mitragotri; Mark R Prausnitz
Journal:  AAPS PharmSciTech       Date:  2010-06-08       Impact factor: 3.246

2.  Injectable chemotherapeutic microspheres and glioma II: enhanced survival following implantation into deep inoperable tumors.

Authors:  D F Emerich; S R Winn; P Snodgrass; D LaFreniere; M Agostino; T Wiens; H Xiong; R T Bartus
Journal:  Pharm Res       Date:  2000-07       Impact factor: 4.200

3.  Injectable chemotherapeutic microspheres and glioma I: enhanced survival following implantation into the cavity wall of debulked tumors.

Authors:  D F Emerich; S R Winn; Y Hu; J Marsh; P Snodgrass; D LaFreniere; T Wiens; B P Hasler; R T Bartus
Journal:  Pharm Res       Date:  2000-07       Impact factor: 4.200

4.  Local epicardial inotropic drug delivery allows targeted pharmacologic intervention with preservation of myocardial loading conditions.

Authors:  Mark A Lovich; Abraham E Wei; Mikhail Y Maslov; Peter I Wu; Elazer R Edelman
Journal:  J Pharm Sci       Date:  2011-06-30       Impact factor: 3.534

Review 5.  Localized delivery of proteins in the brain: can transport be customized?

Authors:  M F Haller; W M Saltzman
Journal:  Pharm Res       Date:  1998-03       Impact factor: 4.200

Review 6.  Experimental methods and transport models for drug delivery across the blood-brain barrier.

Authors:  Bingmei M Fu
Journal:  Curr Pharm Biotechnol       Date:  2012-06       Impact factor: 2.837

Review 7.  Pharmacokinetics of the carmustine implant.

Authors:  Alison B Fleming; W Mark Saltzman
Journal:  Clin Pharmacokinet       Date:  2002       Impact factor: 6.447

8.  Delayed clearance of cerebrospinal fluid tracer from entorhinal cortex in idiopathic normal pressure hydrocephalus: A glymphatic magnetic resonance imaging study.

Authors:  Per K Eide; Geir Ringstad
Journal:  J Cereb Blood Flow Metab       Date:  2018-02-27       Impact factor: 6.200

9.  Drug transport in brain via the cerebrospinal fluid.

Authors:  William M Pardridge
Journal:  Fluids Barriers CNS       Date:  2011-01-18

10.  Peripheral-to-central immune communication at the area postrema glial-barrier following bleomycin-induced sterile lung injury in adult rats.

Authors:  David G Litvin; Scott J Denstaedt; Lauren F Borkowski; Nicole L Nichols; Thomas E Dick; Corey B Smith; Frank J Jacono
Journal:  Brain Behav Immun       Date:  2020-02-22       Impact factor: 7.217

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.